Hepatic Impairment After oral administration of only one 4 mg dose (two mg hydromorphone rapid-release tablets), suggest exposure to hydromorphone (Cmax and AUC?) is amplified 4-fold in patients with reasonable (Child-Pugh Team B) hepatic impairment when compared with subjects with typical hepatic operate. Because of improved exposure of hydromorph